Edition:
United Kingdom

People: Misonix Inc (MSON.OQ)

MSON.OQ on NASDAQ Stock Exchange Global Market

16.10USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$16.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,904
52-wk High
$21.40
52-wk Low
$8.50

Ludecker, Robert 

Mr. Robert Scott Ludecker is Senior Vice President - Global Sales and Marketing of the Company. Mr. Ludecker became Senior Vice President of Global Sales and Marketing in May 2015. Prior to joining the Company as Global Vice President of Sales and Marketing in May 2013, Mr. Ludecker served from February 2011 to May 2013 as Vice President of Global Sales and Marketing for BioMimetic Therapeutics, a NASDAQ-listed biotechnology company, specializing in the development and commercialization of products which promote the healing of musculoskeletal injury and diseases, including orthopedic, spine, and sports medicine applications. Prior to BioMimetic, Mr. Ludecker served from February 2008 to February 2011 in a variety of senior sales and marketing leadership positions with Small Bone Innovations, a private New York City-based orthopedic company specializing in small bones, and Smith and Nephew, a leading U.K.-based global provider of orthopedic reconstruction implants and a broad portfolio of medical instruments and supplies. Mr. Ludecker holds a B. A. degree from Kenyon College.

Basic Compensation

Total Annual Compensation, USD 354,317
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 295,550
Fiscal Year Total, USD 649,867

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --